ClinicalTrials.Veeva

Menu

EarlySense Monitoring Device Evaluation on CHF Patients

E

EarlySense

Status

Withdrawn

Conditions

Congestive Heart Failure

Treatments

Device: EarlySense monitoring device

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT00382746
ES- CI 02

Details and patient eligibility

About

CHF patients will be monitored using EarlySense ES-16 device and will simultaneously fill diaries and log their weight daily. The data collected and analyzed by the ES-16 device will be correlated with the CHF status data.

Sex

All

Ages

45+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age over 45 years old
  • CHF class II or III with LVEF<40%
  • Hospitalized at least once for CHF deterioration over previous 12 month period
  • Able and willing to cooperate with this trial for at least a 3 month period
  • Home close to participating center

Exclusion criteria

  • Recent (within 3 month) admission to ICU or CC-ICU due to severe CHF episode requiring artificial ventilation
  • Asthma or COPD

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems